About the Center

The Center for Lymphoid Malignancies at the Columbia University Medical Center is a newly established initiative that is exclusively focused on the care of patients with lymphoid blood cancers (non-Hodgkin’s lymphoma and Hodgkin ’s disease. It is now estimated that there are over 70 different types of lymphoid cancers, a spectrum of disease that encompasses some of the fastest, and slowest growing diseases known to science (see Patient Care).

The physicians and staff in the Center have extensive experience managing all forms of non-Hodgkin’s lymphoma (NHL) including, for example, peripheral T-cell lymphoma (PTCL), diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), follicular lymphoma (FL), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia/lymphoma (ALL), cutaneous T-cell lymphoma and lymphomas of the brain, as well as Hodgkin Lymphoma. The Center offers a truly multidisciplinary and individualized approach to the care of every patient. At the core of the Centers' activities is an emphasis on translating the latest scientific discoveries and developments into the most promising and innovative treatments for patients suffering from these diverse and complex diseases. This emphasis on translational medicine has allowed our physicians (see Our Physicians) to pioneer several new treatments for many difficult sub-types of lymphoma. In addition, because our physicians are contributing to the development of new ways to manage these diseases, they are at the forefront of knowing the latest emerging trends in lymphoma care; usually well in advance of this information becoming available to the general public or even the medical community.